Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000365601

Medchemexpress LLC Eribulin mesylate | 441045-17-6 | 99.3% | 826.00 | 10 MG
SDP

Catalog No. 5000365601
Encompass_Preferred

Eribulin mesylate is a microtubule targeting agent designed for metastatic breast cancer research. It effectively inhibits the proliferation of cancer cells by binding to microtubule proteins and microtubules, demonstrating significant activity both in vitro and in vivo.

  • Inhibits cell proliferation in various cancer cell lines.
  • Induces early apoptosis and G2/M arrest in LM8 cells.
  • Suppresses cell migration at low concentrations.
  • Reduces primary tumor growth and lung metastasis in osteosarcoma models.
  • Suppresses circulating tumor cells.

Catalog No. 50-003-65601 Supplier Medchemexpress LLC Supplier No. 10MGHY13442A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Eribulin mesylate is a microtubule targeting agent designed for metastatic breast cancer research. It effectively inhibits the proliferation of cancer cells by binding to microtubule proteins and microtubules, demonstrating significant activity both in vitro and in vivo.

  • Inhibits cell proliferation in various cancer cell lines.
  • Induces early apoptosis and G2/M arrest in LM8 cells.
  • Suppresses cell migration at low concentrations.
  • Reduces primary tumor growth and lung metastasis in osteosarcoma models.
  • Suppresses circulating tumor cells.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.